Sign In
Buy PRPH
$0.0900
+0.0120 (+15.38%)
At Close: Jun 23, 2026
ProPhase Labs to Host Second Quarter 2022 Financial Results Conference Call on Thursday, August 11, 2022 at 11:00 a.m. Eastern Time
08:33pm, Thursday, 04'th Aug 2022
GARDEN CITY, NY, Aug. 04, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth oriented and diversified diagnostics, genomics and biotech company, will hold a conference call on Thur
Strength Seen in ProPhase Labs, Inc. (PRPH): Can Its 8% Jump Turn into More Strength?
08:32am, Tuesday, 26'th Jul 2022
ProPhase Labs, Inc. (PRPH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the ne
ProPhase Labs: A Growth Stock At An Attractive Valuation
05:57pm, Monday, 25'th Jul 2022
ProPhase Labs has expanded its in-house testing capabilities for the diagnostics of the new clinical chemistry, immunoassay, hematology, hemostasis, and urinalysis analyzers. ProPhase Labs has success
5 Stocks With Recent Price Strength for a Steady Portfolio
07:45am, Monday, 11'th Jul 2022
Investors target stocks that are witnessing a bullish run. Some of the stocks seeing price strength are USAK, FC, PRPH, DQ and CHEF.
ProPhase Labs, Inc. (PRPH) Soars 9.1%: Is Further Upside Left in the Stock?
09:20am, Friday, 08'th Jul 2022
ProPhase Labs, Inc. (PRPH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price
ProPhase Labs: Healthcare Done Right
09:29pm, Tuesday, 28'th Jun 2022
100% technical buy signals. 12 new highs and up 53.07% in the last month.
ProPhase Labs, Inc. (PRPH) Surges 7.6%: Is This an Indication of Further Gains?
11:35am, Wednesday, 22'nd Jun 2022
ProPhase Labs, Inc. (PRPH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength
Is ProPhase Labs (PRPH) Outperforming Other Medical Stocks This Year?
11:17am, Monday, 13'th Jun 2022
Here is how ProPhase Labs, Inc. (PRPH) and RVL Pharmaceuticals PLC (RVLP) have performed compared to their sector so far this year.
Has ProPhase Labs (PRPH) Outpaced Other Medical Stocks This Year?
11:18am, Thursday, 26'th May 2022
Here is how ProPhase Labs, Inc. (PRPH) and RVL Pharmaceuticals PLC (RVLP) have performed compared to their sector so far this year.
ProPhase Labs, Inc. (PRPH) Moves to Strong Buy: Rationale Behind the Upgrade
01:33pm, Tuesday, 24'th May 2022
ProPhase Labs, Inc. (PRPH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
ProPhase Labs to Present at the H.C. Wainwright 2022 Global Investment Conference
08:15am, Wednesday, 18'th May 2022
May 23-26, 2022 (HYBRID CONFERENCE)
ProPhase Labs, Inc. (PRPH) CEO Ted Karkus on Q1 2022 Results - Earnings Call Transcript
02:22pm, Friday, 13'th May 2022
ProPhase Labs, Inc. (NASDAQ:PRPH ) Q1 2022 Earnings Conference Call May 13, 2022 11:00 AM ET Company Participants Ted Karkus – Chairman & Chief Executive Officer Conference Call Participants Yi Chen
ProPhase Labs to Present at the Spring Into Action – Best Ideas Virtual Investor Conference
06:25pm, Wednesday, 11'th May 2022
Garden City, NY, May 11, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified diagnostics and genomics company, today announced that Chairman and CEO Ted Karkus will present at t
ProPhase Labs to Host First Quarter 2022 Financial Results Conference Call on Friday, May 13, 2022 at 11:00 a.m. Eastern Time
04:30pm, Friday, 06'th May 2022
GARDEN CITY, NY, May 06, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified diagnostics and genomics company, will hold a conference call on Friday, May 13, 2022 at 11:00 a.m.
ProPhase Labs to Present at the Planet MicroCap Showcase 2022 on Wednesday, May 4, 2022
08:15am, Wednesday, 27'th Apr 2022
Garden City, NY, April 27, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified diagnostics and genomics company, today announced that Chairman and CEO Ted Karkus will present a
